HC Wainwright Cuts Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target to $11.00
Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) had its price target trimmed by HC Wainwright from $15.00 to $11.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Acumen Pharmaceuticals’ FY2029 earnings at ($2.03) EPS. Acumen Pharmaceuticals Stock Down […]
Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) had its price target trimmed by HC Wainwright from $15.00 to $11.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Acumen Pharmaceuticals’ FY2029 earnings at ($2.03) EPS. Acumen Pharmaceuticals Stock Down […]
